Jobs

Currently 3941 jobs

Candidates Login

CV Database

Let the jobs come to you!

Company Login

Site Newsletter

Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

PharmiWeb on Facebook

Advertising

Press Releases

submit a press release

238 Press Releases

1 2 3 4 5 6 7 8

Date	Title	Company
30 Nov 12	Teva to Host Conference Call and Webcast on November 30, 2012	Teva Pharmaceutical Industries Ltd., Published by Business Wire
05 Nov 12	Teva Announces Changes to Executive Leadership Team	Teva Pharmaceutical Industries Ltd., Published by Business Wire
01 Nov 12	Teva Reports Third Quarter 2012 Results	Teva Pharmaceutical Industries Ltd., Published by Business Wire
26 Oct 12	Teva Receives Approval For SYNRIBOTM (Omacetaxine Mepesuccinate) for Injection	Teva Pharmaceutical Industries Ltd., Published by Business Wire
22 Oct 12	Phase IIa Laquinimod Trial Results Show Positive Data for Potential Use in Active Crohn's Disease	Teva Pharmaceutical Industries Ltd., Published by Business Wire
17 Oct 12	Teva to Report Third Quarter 2012 Financial Results on November 1, 2012	Teva Pharmaceutical Industries Ltd., Published by Business Wire
15 Oct 12	Teva to Present Positive Data for Glatiramer Acetate 40 mg/1 ml Given Three Times Weekly for Relapsing-Remitting MS	Teva Pharmaceutical Industries Ltd.
10 Oct 12	Teva to Present Positive Data for Glatiramer Acetate 40 mg/1 ml Given Three Times Weekly for Relapsing-Remitting Multiple Sclerosis	Teva Pharmaceutical Industries Ltd., Published by Business Wire
08 Oct 12	New Data Presented at the 28th ECTRIMS Congress Showcase Teva’s Ongoing Commitment to Multiple Sclerosis Research	Teva Pharmaceutical Industries Ltd., Published by Business Wire
14 Sep 12	Bayer HealthCare to Acquire U.S. Animal Health Business From Teva Pharmaceutical Industries	Teva Pharmaceutical Industries Ltd., Published by Business Wire
13 Sep 12	Teva Pharmaceutical Announces the Appointment of Professor Itzhak Krinsky as Chairman of Teva Japan and Teva South Korea and Head of Business Development in Asia-Pacific	Teva Pharmaceutical Industries Ltd., Published by Business Wire
30 Aug 12	Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia	Teva Pharmaceutical Industries Ltd., Published by Business Wire
18 Aug 12	Teva Announces Launch of Generic ACTOplus met® in the United States	Teva Pharmaceutical Industries Ltd., Published by Business Wire
17 Aug 12	Teva Announces Launch of Generic Actos® in the United States	Teva Pharmaceutical Industries Ltd., Published by Business Wire
08 Aug 12	Teva to Initiate Third Phase III Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis	Teva Pharmaceutical Industries Ltd., Published by Business Wire
02 Aug 12	Teva Pharmaceutical Announces New Appointments of President and Chief Executive Officer, Global Operations and Executive Vice President, Community and Institutional Affairs	Teva Pharmaceutical Industries Ltd., Published by Business Wire
02 Aug 12	Teva Reports Second Quarter 2012 Results	Teva Pharmaceutical Industries Ltd., Published by Business Wire
13 Jul 12	Teva to Report Second Quarter 2012 Financial Results on August 2, 2012	Teva Pharmaceutical Industries Ltd., Published by Business Wire
11 Jul 12	Teva Announces Favorable United Kingdom Court Ruling In COPAXONE® Patent Litigation Proceeding	Teva Pharmaceutical Industries Ltd., Published by Business Wire
30 Jun 12	Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy	Teva Pharmaceutical Industries Ltd., Published by Business Wire
23 Jun 12	Teva Announces Favorable Court Ruling in COPAXONE® Patent Infringement Litigation	Teva Pharmaceutical Industries Ltd., Published by Business Wire
22 Jun 12	Teva Announces Launch of Generic Symbyax® in the United States	Teva Pharmaceutical Industries Ltd., Published by Business Wire
14 Jun 12	Teva Announces Top-Line Results from GALA Phase III Trial Evaluating a New Dosage for Glatiramer Acetate Given Three Times Weekly for Relapsing-Remitting Multiple Sclerosis	Teva Pharmaceutical Industries Ltd., Published by Business Wire
13 Jun 12	Teva Announces AZILECT® (Rasagiline Tablets) Data to Be Presented at the 16th Annual International Congress of Parkinson’s Disease and Movement Disorders	Teva Pharmaceutical Industries Ltd., Published by Business Wire
05 Jun 12	Teva to Present at the Jefferies 2012 Global Healthcare Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
05 Jun 12	Teva to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
02 Jun 12	Teva Pharmaceutical Industries Ltd. Chairman of the Board Dr. Phillip Frost Purchases 1 Million Teva Shares	Teva Pharmaceutical Industries Ltd., Published by Business Wire
31 May 12	Teva Begins Trading on the New York Stock Exchange	Teva Pharmaceutical Industries Ltd., Published by Business Wire
30 May 12	Teva to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference	Teva Pharmaceutical Industries Ltd., Published by Business Wire
24 May 12	Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40	Teva Pharmaceutical Industries Ltd., Published by Business Wire

1 2 3 4 5 6 7 8

subscribe in a reader

Advertising

Share | | |

Site Map
Privacy & Security
Cookies
Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.